Top Markets
#1 Pleasing Gold Pleasing Gold +738.04%
#2 Islamic Coin Islamic Coin +154.23%
#3 PulseChain PulseChain +56.20%
#4 BOOK OF MEME BOOK OF MEME +40.59%
#5 DogBull DogBull +37.66%
#6 Collect on Fanable Collect on Fanable +26.22%
#7 Nockchain Nockchain +20.02%
#8 Neiro Neiro +18.83%
#9 rsERG rsERG +17.72%
#10 PondCoin PondCoin +17.19%
Coin of the day
Pleasing Gold Pleasing Gold
Settings
Language
ENGLISH
Currency
USD
Theme
Oncoinvent ASA Oncoinvent ASA

Oncoinvent ASA

ONCIN
Rank in Stocks #26813
Oncoinvent ASA, a clinical-stage firm based in Oslo, Norway, is dedicated to... Oncoinvent ASA, a clinical-stage firm based in Oslo, Norway, is dedicated to developing innovative radiopharmaceutical treatments for various cancers. Its primary therapeutic agent is Radspherin, an alpha-emitting radiotherapeutic, which is currently undergoing investigation in two Phase 1/2a and one randomized Phase 2 clinical trials. This promising candidate is designed to target and treat malignancies that have metastasized to body cavities, specifically including the peritoneum.
Share Price
$8.39
Market Cap
$37.55M
Change (1 day)
-7.83%
Change (1 year)
-26.06%
Country
NO
Trade Oncoinvent ASA (ONCIN)

Category

Healthcare
P/E ratio for Oncoinvent ASA (ONCIN)
P/E ratio as of 2026 TTM: 0
According to Oncoinvent ASA latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is 0. At the end of 2026 the company had a P/E ratio of 0.
P/E ratio history for Oncoinvent ASA from 2026 to 2026
P/E ratio at the end of each year
Year P/E Ratio Change
Not enough data for the provided dates.
P/E ratio for similar companies or competitors
Company P/E Ratio P/E Ratio Difference Country
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 29.20 -
US
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 -7.93 -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 30.62 -
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
 32.46 -
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH
How to read a P/E ratio?

The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share.
A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.

Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.

Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.